Geron Corp. buy klostergang
Start price
26.06.15
/
50%
€3.58
Target price
07.12.15
€4.50
Performance (%)
29.46%
End price
07.12.15
€4.63
Summary
This prediction ended on 07.12.15 with a price of €4.63. The prediction had a final performance of 29.46%. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Geron Corp. | 8.236% | 8.236% | 53.652% | 277.893% |
iShares Core DAX® | 0.443% | 0.771% | 16.335% | 15.985% |
iShares Nasdaq 100 | -0.150% | 4.094% | 36.047% | 50.709% |
iShares Nikkei 225® | 2.566% | 4.202% | 15.033% | 10.588% |
iShares S&P 500 | 0.479% | 2.881% | 29.113% | 45.053% |
Comments by klostergang for this prediction
In the thread Geron Corp. diskutieren
Mit JNJ-Partnerschaft und Orphan Drug der FDA gegen Krebs :
Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.
(Vom Mitglied beendet)